November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreFebruary 20, 2026
Our projections indicate that, the pharmaceutical contract manufacturing and research services market was valued at USD 281.68 billion in 2025 and is projected to reach USD 301.23 billion in 2026, further expanding to USD 551.01 billion by 2035, growing at a CAGR of 6.94% (2026–2035)....
February 19, 2026
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expanding due to growing innovations....
February 19, 2026
According to our projections, the high potency active pharmaceutical ingredients market was valued at USD 30.86 billion in 2025 and reached USD 33.45 billion in 2026, and is projected to grow significantly to USD 69.13 billion by 2035, expanding at a CAGR of 8.4% from 2026 to 2035....
February 16, 2026
According to our projections, the API stability testing services market was valued at USD 1.48 billion in 2025 and is projected to reach USD 1.55 billion in 2026, further expanding to USD 2.35 billion by 2035 at a CAGR of 4.74% (2026–2035)....
February 12, 2026
Based on our estimations, the medical radioactive iodine I-131 market was valued at USD 811 million in 2025 and is estimated to reach USD 862.74 million in 2026, further projected to grow to USD 1,505.29 million by 2035, expanding at a CAGR of 6.38% during 2026–2035....
February 11, 2026
Based on our estimations, the pharmaceutical CRO and CDMO market was valued at USD 254.65 billion in 2025 and is estimated to reach USD 277.16 billion in 2026, with the market projected to expand to USD 594.07 billion by 2035, registering a CAGR of 8.84% from 2026 to 2035....
February 10, 2026
Based on our estimations, the commercial drug manufacturing market was valued at USD 1.97 billion in 2025 and is expected to reach USD 2.08 billion in 2026, growing further to approximately USD 3.41 billion by 2035 at a CAGR of 5.64% during 2026–2035....
February 10, 2026
Based on our research, the drug product development service market was valued at USD 340.04 million in 2025 and is projected to reach USD 350.38 million in 2026, expanding further to USD 458.76 million by 2035 at a CAGR of 3.04%....
February 09, 2026
The global GMP drug substance market was USD 2.71 billion in 2025 and is projected to reach USD 4.91 billion by 2035 at a CAGR of 6.14%. Key segments include viral vectors, cell-based therapies, oligonucleotides, and biologics. North America leads, with Asia-Pacific growing fastest. The market features top players like AGC Biologics, Catalent, an...
January 30, 2026
According to our insight calculates, the plant-based excipients market was valued at USD 2.09 billion in 2025 and is expected to reach USD 2.18 billion in 2026, growing steadily to USD 3.19 billion by 2035 at a CAGR of 4.32% from 2026 to 2035....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com